Literature DB >> 32253661

Apathy is Associated with Critical Psychological Determinants of Medication Adherence in HIV Disease.

Michelle A Babicz1, Steven Paul Woods2, Pariya Fazeli3, Erin E Morgan4.   

Abstract

Apathy is common in HIV, separable from depression, and has been associated with non-adherence to antiretroviral therapy (ART). We examined the associations between apathy and critical psychological determinants of ART adherence, as per the information-motivation-behavioral model, in 85 persons living with HIV. Apathy was measured using a composite of the apathy subscale of the Frontal Systems Behavioral Scale and the vigor-activation scale of the Profile of Mood States. Independent of major depressive disorder, apathy was related at small-to-medium effect sizes with motivation to adhere and self-efficacy for health-related decision-making and medication management, but not with HIV knowledge or medication management skills. These findings suggest that apathy plays a unique role in several critical health adherence determinants and support the importance of assessment and management of apathy to maximize health outcomes among individuals with HIV disease.

Entities:  

Keywords:  Apathy; HIV/AIDS; Medication adherence; Motivation; Neuropsychiatry

Mesh:

Year:  2021        PMID: 32253661      PMCID: PMC7541422          DOI: 10.1007/s10880-020-09715-7

Source DB:  PubMed          Journal:  J Clin Psychol Med Settings        ISSN: 1068-9583


  64 in total

Review 1.  Virologic correlates of adherence to antiretroviral medications and therapeutic failure.

Authors:  Carlo Federico Perno; Francesca Ceccherini-Silberstein; Andrea De Luca; Alessandro Cozzi-Lepri; Caterina Gori; Antonella Cingolani; Maria Concetta Bellocchi; Maria Paola Trotta; Paola Piano; Federica Forbici; Antonio Scasso; Vincenzo Vullo; Antonella d'Arminio Monforte; Andrea Antinori
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

2.  A pilot study examining older adults' beliefs related to medication adherence: the BERMA survey.

Authors:  Leslie McDonald-Miszczak; Paula Maris; Tracy Fitzgibbon; Gina Ritchie
Journal:  J Aging Health       Date:  2004-11

3.  Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

4.  Stability in Test-Usage Practices of Clinical Neuropsychologists in the United States and Canada Over a 10-Year Period: A Follow-Up Survey of INS and NAN Members.

Authors:  Laura A Rabin; Emily Paolillo; William B Barr
Journal:  Arch Clin Neuropsychol       Date:  2016-03-16       Impact factor: 2.813

5.  Syndromic validity of apathy in Alzheimer's disease.

Authors:  S E Starkstein; G Petracca; E Chemerinski; J Kremer
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

6.  Apathy and its treatment.

Authors:  Robert M Roth; Laura A Flashman; Thomas W McAllister
Journal:  Curr Treat Options Neurol       Date:  2007-09       Impact factor: 3.598

7.  Apathy correlates with cognitive performance, functional disability, and HIV RNA plasma levels in HIV-positive individuals.

Authors:  Miriam E Shapiro; Jeannette R Mahoney; Barry S Zingman; David L Pogge; Joe Verghese
Journal:  J Clin Exp Neuropsychol       Date:  2013-10-04       Impact factor: 2.475

8.  Apathy, depression, and cognitive performance in HIV-1 infection.

Authors:  S A Castellon; C H Hinkin; S Wood; K T Yarema
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1998       Impact factor: 2.198

Review 9.  Apathy associated with neurocognitive disorders: Recent progress and future directions.

Authors:  Krista L Lanctôt; Luis Agüera-Ortiz; Henry Brodaty; Paul T Francis; Yonas E Geda; Zahinoor Ismail; Gad A Marshall; Moyra E Mortby; Chiadi U Onyike; Prasad R Padala; Antonios M Politis; Paul B Rosenberg; Emma Siegel; David L Sultzer; Eleenor H Abraham
Journal:  Alzheimers Dement       Date:  2016-06-27       Impact factor: 21.566

10.  The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART.

Authors:  Viviane D Lima; Josie Geller; David R Bangsberg; Thomas L Patterson; Mark Daniel; Thomas Kerr; Julio S G Montaner; Robert S Hogg
Journal:  AIDS       Date:  2007-05-31       Impact factor: 4.177

View more
  3 in total

1.  Apathy is not associated with a panel of biomarkers in older adults with HIV disease.

Authors:  Steven Paul Woods; Jennifer L Thompson; Michelle A Babicz; Lokesh Shahani; Gabriela Delevati Colpo; Natalia P Rocha; Erin E Morgan; Antonio L Teixeira
Journal:  J Psychosom Res       Date:  2021-11-08       Impact factor: 4.620

2.  S-Equol mitigates motivational deficits and dysregulation associated with HIV-1.

Authors:  Kristen A McLaurin; Sarah J Bertrand; Jessica M Illenberger; Steven B Harrod; Charles F Mactutus; Rosemarie M Booze
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

3.  Relationship between reward-related evoked potentials and real-world motivation in older people living with human immunodeficiency virus.

Authors:  Gloria Castaneda; Ana-Lucia Fernandez Cruz; Marie-Josée Brouillette; Nancy E Mayo; Lesley K Fellows
Journal:  Front Aging Neurosci       Date:  2022-09-01       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.